Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122313 · ClinicalTrials.gov registry record

Post-contracture Release Radiation for Dupuytren's Disease

A clinical trial of Dupuytren Contracture and Dupuytren's Disease, sponsored by University of Minnesota.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT04122313 is a study of Dupuytren Contracture and Dupuytren's Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 50 participants, below the 86-participant average among 4 other Dupuytren Contracture trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122313, a study of Dupuytren Contracture and Dupuytren's Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.

Interventions

  • OTHER Evaluation of Dupuytren's Disease Treatment

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-05-31
Est. Completion 2029-03-01

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04122313

The ClinicalTrials.gov registry entry for NCT04122313 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 4 other Dupuytren Contracture trials with a reported enrollment target (42% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Dupuytren Contracture appearing as the primary indexed condition, and to 1 intervention - of which Evaluation of Dupuytren's Disease Treatment is the first listed.

NCT04122313 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04122313 about?

NCT04122313 is a clinical study titled "Post-contracture Release Radiation for Dupuytren's Disease". To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.

What is the current status of trial NCT04122313?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2019-05-31. Estimated completion is 2029-03-01.

What conditions does trial NCT04122313 study?

This clinical trial studies the following conditions: Dupuytren Contracture, Dupuytren's Disease, Dupuytren Disease of Palm and Finger, Dupuytren Disease of Finger, Dupuytrens Contracture of Both Hands.

What interventions are being tested in trial NCT04122313?

The interventions under investigation include: Evaluation of Dupuytren's Disease Treatment (OTHER).

Who is sponsoring clinical trial NCT04122313?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122313 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dupuytren Contracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.